{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:45Z","timestamp":1792785045762,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"LUF\/Stichting Prof. Jaap de Graeff-Lingling Wiyadharma Fonds","award":["2020-01"],"award-info":[{"award-number":["2020-01"]}]},{"name":"Novo Nordisk Foundation Center for Stem Cell Medicine","award":["NNF21CC0073729"],"award-info":[{"award-number":["NNF21CC0073729"]}],"id":[{"id":"https:\/\/ror.org\/03nqjyg83","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58651-3","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:34:13Z","timestamp":1782218053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR-Cas9-mediated knock-in of cytomegalovirus US2 provides an alternative strategy for generating hypoimmunogenic hiPSC lines"],"prefix":"10.1038","volume":"16","author":[{"given":"Juan J.","family":"Novoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke H.","family":"Gaykema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette A.","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke H. D.","family":"Peerlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne Y.","family":"van Nieuwland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"van der Slik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francijna E.","family":"van den Hil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria V.","family":"Orlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A. F. V.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathelijne W.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton J.","family":"Rabelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Zaldumbide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"58651_CR1","doi-asserted-by":"publisher","unstructured":"Riolobos, L. et al. HLA engineering of human pluripotent stem cells. Mol. Ther. 21 (6), 1232\u20131241. https:\/\/doi.org\/10.1038\/mt.2013.59 (2013).","DOI":"10.1038\/mt.2013.59"},{"key":"58651_CR2","doi-asserted-by":"publisher","unstructured":"Lu, P. et al. Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin. Stem Cell Rev. Rep. 9(6),  806\u2009\u2013\u2009813. https:\/\/doi.org\/10.1007\/s12015-013-9457-0 (2013).","DOI":"10.1007\/s12015-013-9457-0"},{"key":"58651_CR3","doi-asserted-by":"publisher","unstructured":"Heegaard, N. H. Beta(2)-microglobulin: From physiology to amyloidosis (in Eng). Amyloid 16(3),  151\u2009\u2013\u2009173. https:\/\/doi.org\/10.1080\/13506120903151775 (2009).","DOI":"10.1080\/13506120903151775"},{"key":"58651_CR4","doi-asserted-by":"publisher","unstructured":"Bix, M. et al. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice (in Eng). Nature 349(6307),  329\u2009\u2013\u2009331. https:\/\/doi.org\/10.1038\/349329a0  (1991).","DOI":"10.1038\/349329a0"},{"key":"58651_CR5","doi-asserted-by":"publisher","unstructured":"Gornalusse, G. G. et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells (in Eng). Nat. Biotechnol. 35 (8), 765\u2013772. https:\/\/doi.org\/10.1038\/nbt.3860 (2017).","DOI":"10.1038\/nbt.3860"},{"key":"58651_CR6","doi-asserted-by":"publisher","unstructured":"Guo, Y. et al. Mutant B2M-HLA-E and B2M-HLA-G fusion proteins protects universal chimeric antigen receptor-modified T cells from allogeneic NK cell-mediated lysis (in Eng). Eur. J. Immunol. 51 (10), 2513\u20132521. https:\/\/doi.org\/10.1002\/eji.202049107 (2021).","DOI":"10.1002\/eji.202049107"},{"key":"58651_CR7","doi-asserted-by":"publisher","unstructured":"Ye, Q. et al. Generation of universal and hypoimmunogenic human pluripotent stem cells. Cell. Prolif. 53 (12), e12946. https:\/\/doi.org\/10.1111\/cpr.12946 (2020).","DOI":"10.1111\/cpr.12946"},{"key":"58651_CR8","doi-asserted-by":"publisher","unstructured":"Wang, D., Quan, Y., Yan, Q., Morales, J. E. & Wetsel, R. A. Targeted disruption of the \u03b22-microglobulin gene minimizes the immunogenicity of human embryonic stem cells (in Eng). Stem Cells Transl. Med.  4(10),  1234-1245. https:\/\/doi.org\/10.5966\/sctm.2015-0049   (2015).","DOI":"10.5966\/sctm.2015-0049"},{"key":"58651_CR9","doi-asserted-by":"publisher","first-page":"707881","DOI":"10.3389\/fendo.2021.707881","volume":"12","author":"R Castro-Gutierrez","year":"2021","unstructured":"Castro-Gutierrez, R., Alkanani, A., Mathews, C. E., Michels, A. & Russ, H. A. Protecting stem cell derived pancreatic beta-like cells from diabetogenic T cell recognition (in Eng). Front. Endocrinol. (Lausanne). 12, 707881. https:\/\/doi.org\/10.3389\/fendo.2021.707881 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"58651_CR10","doi-asserted-by":"publisher","unstructured":"Santos, M. et al. Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J. Exp. Med. 184 (5), 1975\u20131985. https:\/\/doi.org\/10.1084\/jem.184.5.1975 (1996).","DOI":"10.1084\/jem.184.5.1975"},{"key":"58651_CR11","doi-asserted-by":"publisher","unstructured":"Muckenthaler, M. U. et al. Molecular analysis of iron overload in beta2-microglobulin-deficient mice, Blood Cells Mol. Dis. 33(2),  125\u2009\u2013\u2009131. https:\/\/doi.org\/10.1016\/j.bcmd.2004.05.003(2004).","DOI":"10.1016\/j.bcmd.2004.05.003"},{"key":"58651_CR12","doi-asserted-by":"publisher","unstructured":"Zaldumbide, A. & Hoeben, R. C. How not to be seen: Immune-evasion strategies in gene therapy. Gene Ther. 15(4),  239\u2009\u2013\u2009246. https:\/\/doi.org\/10.1038\/sj.gt.3303082 (2008).","DOI":"10.1038\/sj.gt.3303082"},{"key":"58651_CR13","doi-asserted-by":"publisher","first-page":"730765","DOI":"10.3389\/fimmu.2021.730765","volume":"12","author":"RE Baba","year":"2021","unstructured":"Baba, R. E. & Herbein, G. Immune landscape of CMV infection in cancer patients: From canonical diseases toward virus-elicited oncomodulation. Front. Immunol. 12, 730765. https:\/\/doi.org\/10.3389\/fimmu.2021.730765 (2021).","journal-title":"Front. Immunol."},{"key":"58651_CR14","doi-asserted-by":"publisher","unstructured":"Berry, R., Watson, G. M., Jonjic, S., Degli-Esposti, M. A. & Rossjohn, J. Modulation of innate and adaptive immunity by cytomegaloviruses. Nat. Rev. Immunol. 20, 2,  113\u2013127. https:\/\/doi.org\/10.1038\/s41577-019-0225-5 (2020).","DOI":"10.1038\/s41577-019-0225-5"},{"key":"58651_CR15","doi-asserted-by":"publisher","unstructured":"Stern-Ginossar, N. et al. Decoding human cytomegalovirus (in Eng). Science 338(6110),  1088-1093. https:\/\/doi.org\/10.1126\/science.1227919 (2012).","DOI":"10.1126\/science.1227919"},{"issue":"4","key":"58651_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0952-7915(00)00239-9","volume":"13","author":"BE Gewurz","year":"2001","unstructured":"Gewurz, B. E., Gaudet, R., Tortorella, D., Wang, E. W. & Ploegh, H. L. Virus subversion of immunity: A structural perspective. Curr. Opin. Immunol. 13 (4), 442\u2013450. https:\/\/doi.org\/10.1016\/S0952-7915(00)00239-9 (2001). 2001\/08\/01\/.","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"58651_CR17","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.4049\/jimmunol.171.12.6757","volume":"171","author":"MT Barel","year":"2003","unstructured":"Barel, M. T. et al. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation1. J. Immunol. 171 (12), 6757\u20136765. https:\/\/doi.org\/10.4049\/jimmunol.171.12.6757 (2003).","journal-title":"J. Immunol."},{"key":"58651_CR18","doi-asserted-by":"publisher","unstructured":"Llano, M., Guma, M., Ortega, M., Angulo, A. & Lopez-Botet, M. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: Impact on target susceptibility to NK cell subsets. Eur. J. Immunol. 33 (10), 2744\u20132754. https:\/\/doi.org\/10.1002\/eji.200324182 (2003).","DOI":"10.1002\/eji.200324182"},{"key":"58651_CR19","doi-asserted-by":"publisher","unstructured":"Shao, Y. et al. Vascular endothelial cells and innate immunity. Arterioscler. Thromb. Vasc Biol. 40 (6), e138\u2013e152. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314330 (2020).","DOI":"10.1161\/ATVBAHA.120.314330"},{"key":"58651_CR20","doi-asserted-by":"publisher","unstructured":"Barel, M. T., Pizzato, N., Le Bouteiller, P., Wiertz, E. J. H. J. & Lenfant, F. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation (in English). Int. Immunol. 18 (1), 173\u2013182. https:\/\/doi.org\/10.1093\/intimm\/dxh362 (2006).","DOI":"10.1093\/intimm\/dxh362"},{"key":"58651_CR21","doi-asserted-by":"publisher","unstructured":"Xu, H. et al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24(4), 566\u2013578 e7. https:\/\/doi.org\/10.1016\/j.stem.2019.02.005 (2019).","DOI":"10.1016\/j.stem.2019.02.005"},{"key":"58651_CR22","doi-asserted-by":"publisher","unstructured":"Lee, N. et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A (in Eng). Proc. Natl. Acad. Sci. USA 95(9),  5199\u2009\u2013\u20095254. https:\/\/doi.org\/10.1073\/pnas.95.9.5199 (1998).","DOI":"10.1073\/pnas.95.9.5199"},{"key":"58651_CR23","doi-asserted-by":"publisher","unstructured":"Zaldumbide, A. et al. Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo (in Eng). Mol. Ther. 21(8),  1592\u2009\u2013\u20091611. https:\/\/doi.org\/10.1038\/mt.2013.105 (2013).","DOI":"10.1038\/mt.2013.105"},{"key":"58651_CR24","doi-asserted-by":"publisher","unstructured":"Machold, R. P., Wiertz, E. J., Jones, T. R. & Ploegh, H. L. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185 (2), 363\u2013366. https:\/\/doi.org\/10.1084\/jem.185.2.363 (1997).","DOI":"10.1084\/jem.185.2.363"},{"key":"58651_CR25","doi-asserted-by":"publisher","unstructured":"Hsu, J. L. et al. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog. 11 (4), e1004811. https:\/\/doi.org\/10.1371\/journal.ppat.1004811 (2015) (in Eng).","DOI":"10.1371\/journal.ppat.1004811"},{"key":"58651_CR26","doi-asserted-by":"publisher","unstructured":"van Swelm, R. P. L., Vos, M., Verhoeven, F., Thevenod, F. & Swinkels, D. W. Endogenous hepcidin synthesis protects the distal nephron against hemin and hemoglobin mediated necroptosis. Cell Death Dis. 9(5),  550. https:\/\/doi.org\/10.1038\/s41419-018-0568-z (2018).","DOI":"10.1038\/s41419-018-0568-z"},{"key":"58651_CR27","doi-asserted-by":"publisher","unstructured":"Diepeveen, L. E. et al. Investigating the molecular mechanisms of renal hepcidin induction and protection upon hemoglobin-induced acute kidney injury. Int. J. Mol. Sci. 23 (3). https:\/\/doi.org\/10.3390\/ijms23031352 (2022).","DOI":"10.3390\/ijms23031352"},{"key":"58651_CR28","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Global chromosome rearrangement induced by CRISPR-Cas9 reshapes the genome and transcriptome of human cells. Nucleic Acids Res. 50(6), 3456\u20133474. https:\/\/doi.org\/10.1093\/nar\/gkac153 (2022).","DOI":"10.1093\/nar\/gkac153"},{"key":"58651_CR29","doi-asserted-by":"publisher","unstructured":"Lombardo, A. et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat. Methods 8(10),  861-869. https:\/\/doi.org\/10.1038\/nmeth.1674 (2011).","DOI":"10.1038\/nmeth.1674"},{"key":"58651_CR30","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking. Nucleic Acids Res. 48 (2), 974\u2013995. https:\/\/doi.org\/10.1093\/nar\/gkz1121 (2020).","DOI":"10.1093\/nar\/gkz1121"},{"key":"58651_CR31","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. Precise and broad scope genome editing based on high-specificity Cas9 nickases. Nucleic Acids Res, 49(2), 1173\u20131198. https:\/\/doi.org\/10.1093\/nar\/gkaa1236 (2021).","DOI":"10.1093\/nar\/gkaa1236"},{"key":"58651_CR32","doi-asserted-by":"publisher","unstructured":"Wang, Q., Liu, J., Janssen, J. M. & Goncalves, M. Precise homology-directed installation of large genomic edits in human cells with cleaving and nicking high-specificity Cas9 variants. Nucleic Acids Res. 51(7),  3465\u20133484. https:\/\/doi.org\/10.1093\/nar\/gkad165 (2023).","DOI":"10.1093\/nar\/gkad165"},{"key":"58651_CR33","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat. Commun. 8 (1), 657. https:\/\/doi.org\/10.1038\/s41467-017-00687-1 (2017).","DOI":"10.1038\/s41467-017-00687-1"},{"key":"58651_CR34","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. Probing the impact of chromatin conformation on genome editing tools. Nucleic Acids Res. 44 (13), 6482\u20136492. https:\/\/doi.org\/10.1093\/nar\/gkw524 (2016).","DOI":"10.1093\/nar\/gkw524"},{"key":"58651_CR35","doi-asserted-by":"publisher","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339 (6121), 823\u2013826. https:\/\/doi.org\/10.1126\/science.1232033 (2013).","DOI":"10.1126\/science.1232033"},{"issue":"6","key":"58651_CR36","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nprot.2014.102","volume":"9","author":"VV Orlova","year":"2014","unstructured":"Orlova, V. V. et al. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat. Protoc. 9 (6), 1514\u20131531. https:\/\/doi.org\/10.1038\/nprot.2014.102 (2014).","journal-title":"Nat. Protoc."},{"key":"58651_CR37","doi-asserted-by":"publisher","unstructured":"Tiemeier, G. L. et al. Closing the mitochondrial permeability transition pore in hiPSC-derived endothelial cells induces glycocalyx formation and functional maturation. Stem Cell Rep. 13(5),  803\u2013816. https:\/\/doi.org\/10.1016\/j.stemcr.2019.10.005  (2019).","DOI":"10.1016\/j.stemcr.2019.10.005"},{"key":"58651_CR38","doi-asserted-by":"crossref","unstructured":"Borst, J. et al. Complexity of T cell receptor recognition sites for defined alloantigens. J. Immunol. 139(6),  1952-1959. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2957443 (1987).","DOI":"10.4049\/jimmunol.139.6.1952"},{"key":"58651_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.mcb.2022.05.001","volume":"173","author":"NA Beelen","year":"2023","unstructured":"Beelen, N. A., Ehlers, F. A. I., Kooreman, L. F. S., Bos, G. M. J. & Wieten, L. An in vitro model to monitor natural killer cell effector functions against breast cancer cells derived from human tumor tissue. Methods Cell. Biol. 173, 133\u2013153. https:\/\/doi.org\/10.1016\/bs.mcb.2022.05.001 (2023).","journal-title":"Methods Cell. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58651-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58651-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58651-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:47Z","timestamp":1789556567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58651-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58651"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58651-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors AZ, TR, LG, and JN are inventors on a patent application related to the work described in this manuscript. The application is currently pending.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28802"}}